GGrantIndex
← Search

A PHASE I, DOSE-RISING STUDY: AMD11070 IN HIV-SERONEGATIVE MEN, A5191

$77,302M01FY2005RRNIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

View original record on NIH RePORTER →